Hepatocellular Carcinoma Diagnosis

Hepatocellular carcinoma commonly develops in people with chronic hepatitis B and hepatitis C infections. In the majority of cases (nearly 80%), hepatocellular carcinoma develops following liver cirrhosis caused by these infections or chronic alcoholism.

Liver cancer does not usually present with symptoms until the disease has progressed to an advanced stage and spread to the extent that it can no longer be destroyed with therapy. This means that only around one in five people with this form of cancer live for at least a year after their diagnosis and only one in 20 survive for five years. However, because hepatocellular carcinoma is known to occur in individuals with chronic hepatitis B or hepatitis C, these patients are monitored on a regular basis. The tests used to monitor these high risk individuals are described below.

  • Whole abdomen ultrasound scan is a non-invasive and cost-effective test that uses high-frequency sound waves to create an image of the liver so that any abnormalities can be detected.
  • Blood tests that indicate raised alpha-fetoprotein and des-gamma carboxyprothrombin levels, show that a patient is at a particularly high risk of developing hepatocellular carcinoma.
  • These high risk patients may be advised to have a computed tomography (CT) scan of the abdomen using intravenous contrast agent. The CT scan is performed in three phases including pre-contrast application, immediately after contrast administration, and again at a later stage. This can help locate small tumors and those that are difficult to detect. If cancer is present, the CT scan typically reveals three distinct growth patterns of the cancer, which occurs as a single, large tumor, multiple tumors or poorly defined tumors with an infiltrative growth pattern. The contrasts used are usually iodine or barium. An alternative to CT imaging is magnetic resonance imaging (MRI).
  • To confirm a diagnosis of cancer, a biopsy of the tumor tissue is sometimes performed. The tumor tissue is then examined under a microscope to assess its architectural and cytological type. The four main types of hepatocellular cancer include:
    • Fibrolamellar
    • Pseudoglandular (adenoid)
    • Pleomorphic (giant cell)
    • Clear cell

Further Reading

Last Updated: Feb 26, 2019

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2019, February 26). Hepatocellular Carcinoma Diagnosis. News-Medical. Retrieved on July 19, 2024 from https://www.news-medical.net/health/Hepatocellular-Carcinoma-Diagnosis.aspx.

  • MLA

    Mandal, Ananya. "Hepatocellular Carcinoma Diagnosis". News-Medical. 19 July 2024. <https://www.news-medical.net/health/Hepatocellular-Carcinoma-Diagnosis.aspx>.

  • Chicago

    Mandal, Ananya. "Hepatocellular Carcinoma Diagnosis". News-Medical. https://www.news-medical.net/health/Hepatocellular-Carcinoma-Diagnosis.aspx. (accessed July 19, 2024).

  • Harvard

    Mandal, Ananya. 2019. Hepatocellular Carcinoma Diagnosis. News-Medical, viewed 19 July 2024, https://www.news-medical.net/health/Hepatocellular-Carcinoma-Diagnosis.aspx.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Revolutionary study reveals Lactobacillus acidophilus could ward off liver cancer linked to fatty liver disease